Recipient-derived EBV-positive Monomorphic Plasmacytoma Type Posttransplant Lymphoproliferative Disorder After Allogeneic Stem Cell Transplant for Severe Aplastic Anemia

2016 ◽  
Vol 38 (8) ◽  
pp. e310-e314 ◽  
Author(s):  
Marcus A. Carden ◽  
Shelley Caltharp ◽  
Marianne E. Yee ◽  
Ann E. Haight ◽  
Lars F. Westblade ◽  
...  
2010 ◽  
Vol 52 (1) ◽  
pp. 137-141 ◽  
Author(s):  
Paolo Anderlini ◽  
Sandra A. Acholonu ◽  
Grace-Julia Okoroji ◽  
Roland E. Bassett ◽  
Elizabeth J. Shpall ◽  
...  

2018 ◽  
Vol 89 (6) ◽  
pp. A15.3-A16
Author(s):  
Alice Powell ◽  
Joanne Sy ◽  
Yael Barnett ◽  
Simon Mosalski ◽  
Bruce Brew ◽  
...  

IntroductionPost-transplant lymphoproliferative disorder (PTLD) is a well-recognised serious complication of transplantation. However, it rarely affects muscle.MethodsA case report detailing presentation, evaluation, management and outcome of a patient with acute on chronic proximal myopathy on a background of allogeneic stem cell transplant is described. The patient was diagnosed with PTLD affecting skeletal muscle.ResultsA 54 year old man presented with painful proximal myopathy seven years after successful allogeneic stem cell transplant for acute myeloid leukaemia. He had been managed with immunosuppression for extensive cutaneous graft versus host disease (GVHD) from the time of transplant. Initial quadriceps muscle biopsy showed changes in keeping with GVHD and features suggestive of drug-related necrotising myositis. The painful myalgia evolved to include bulbar muscles with dysphagia despite pulse steroid and intravenous immunoglobulin therapy. A positron emission tomography (PET) scan demonstrated intense and extensive hyper-metabolism in multiple muscle groups in keeping with diffuse myositis with the most prominent activity involving neck muscles, the left shoulder girdle and left arm musculature. A second biopsy of the sternocleidomastoid demonstrated infiltration with haematolymphoid cells consistent with post-transplant lymphoproliferative disorder. Treatment with reduction in immunosuppression, rituximab and rehabilitation saw improvement in myalgia and weakness. Unfortunately, exacerbation of chronic GVHD ensued following reduction in immunosuppression and contributed to oesophageal stricturing eventually requiring a percutaneous endoscopic gastrostomy tube for feeding.ConclusionThis case highlights the complex morbidity of allogeneic stem cell transplant and the need to consider PTLD in the differential for patients who present with neurological symptoms.


2020 ◽  
Vol 42 (8) ◽  
pp. 500-500
Author(s):  
Satya P. Yadav ◽  
Dhwanee Thakkar ◽  
Goutomi Chatterjee ◽  
Rohit Kapoor ◽  
Neha Rastogi

2018 ◽  
Vol 22 (8) ◽  
pp. e13302 ◽  
Author(s):  
Csaba Kassa ◽  
Péter Reményi ◽  
János Sinkó ◽  
Krisztián Kállay ◽  
Gabriella Kertész ◽  
...  

2020 ◽  
Vol 4 (02) ◽  
pp. 49-51
Author(s):  
Tangia Muquith

Epstein –Barr virus related post-transplant lymphoproliferative disorder is a fatal and life-threatening complication because of immunocompromised state.1 Haemophagocytic lymphohistiocytosis is a sign of poor outcome in EBV associated PTLD after allogeneic stem cell transplantation. It is particularly common when in vivo T cell depletion strategies have been applied.2 In both situations, post-transplant lymphoproliferative disorder and Haemophagocytic lymphohistiocytosis, infection with EBV is the key mechanism. Here I present a case of 29 years old female with acute myeloid leukaemia after second allogeneic stem cell transplant, who developed PTLD complicated with Haemophagocytic lymphohistiocytosis secondary to Epstein – Barr virus (EBV) infection. Patient was treated with chemo immunotherapy and responded but ultimately died after 100 days of transplant. The association of HLH and EBV related PTLD is rare and data on outcome of these patients are limited with very high mortality.


Sign in / Sign up

Export Citation Format

Share Document